Neoadjuvant therapy with peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours

被引：0
|
作者：
Hallet, Julie [1 ,2 ]
Soreide, Kjetil [3 ,4 ,5 ]
机构：
[1] Univ Toronto, Dept Surg, 2075 Bayview Ave,T2-102, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Div Surg Oncol, Susan Leslie Clin Neuroendocrine Tumours, Toronto, ON, Canada
[3] Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway
[4] Stavanger Univ Hosp, Lab Mol Med, Gastrointestinal Translat Res Grp, Stavanger, Norway
[5] Univ Bergen, Dept Clin Med, Bergen, Norway
来源：
BRITISH JOURNAL OF SURGERY | 2024年 / 111卷 / 09期
关键词：
D O I：
10.1093/bjs/znae183
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
    Elston, Marianne S.
    Love, Amanda
    Kevat, Dev
    Carroll, Richard
    Siow, Zhen Rong
    Pattison, Sharon
    Boyle, Veronica
    Segelov, Eva
    Strickland, Andrew H.
    Wyld, David
    Gauci, Richard
    Kennedy, Kim
    Ransom, David
    CANCER MEDICINE, 2021, 10 (23): : 8405 - 8411
  • [22] The role of peptide receptor radionuclide therapy in patients with lung neuroendocrine tumours
    Filice, Angelina
    Fraternali, Alessandro
    Fioroni, Federica
    Froio, Armando
    Di Paolo, Maria Liberata
    Casali, Massimiliano
    Roncali, Massimo
    Grassi, Elisa
    Asti, Mattia
    Versari, Annibale
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [23] Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?
    Michael S. Hofman
    Rodney J. Hicks
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 211 - 213
  • [24] Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?
    Hofman, Michael S.
    Hicks, Rodney J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (02) : 211 - 213
  • [25] Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours
    Adant, Samuel
    Shah, Girish M.
    Beauregard, Jean-Mathieu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (04) : 907 - 921
  • [26] Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT)
    Marco Schiavo Lena
    Stefano Partelli
    Paola Castelli
    Valentina Andreasi
    Chanel Elisha Smart
    Eleonora Pisa
    Mirco Bartolomei
    Emilio Bertani
    Giuseppe Zamboni
    Massimo Falconi
    Claudio Doglioni
    Endocrine Pathology, 2020, 31 : 119 - 131
  • [27] Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT)
    Schiavo Lena, Marco
    Partelli, Stefano
    Castelli, Paola
    Andreasi, Valentina
    Smart, Chanel Elisha
    Pisa, Eleonora
    Bartolomei, Mirco
    Bertani, Emilio
    Zamboni, Giuseppe
    Falconi, Massimo
    Doglioni, Claudio
    ENDOCRINE PATHOLOGY, 2020, 31 (02) : 119 - 131
  • [28] Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide Therapy
    Navalkissoor, Shaunak
    Grossman, Ashley
    NEUROENDOCRINOLOGY, 2019, 108 (03) : 256 - 264
  • [29] Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors
    Ramage, John
    Naraev, Boris G.
    Halfdanarson, Thorvardur R.
    SEMINARS IN ONCOLOGY, 2018, 45 (04) : 236 - 248
  • [30] Efficacy of Peptide Receptor Radionuclide Therapy in Patients with Advanced Bronchial Neuroendocrine Tumours
    Koffas, A.
    Popat, R.
    Mohmaduvesh, M.
    Quigley, A. M.
    Navalkissoor, S.
    Caplin, M.
    Toumpanakis, C.
    NEUROENDOCRINOLOGY, 2016, 103 : 81 - 81
12345